Literature DB >> 8615868

Conformational analysis of non-sulfonylurea hypoglycemic agents of the meglitinide family.

L Lins1, R Brasseur, W J Malaisse.   

Abstract

Non-sulfonylurea hypoglycemic agents of the meglitinide family such as S3075, repaglinide, KAD-1229, and A-4166, were found to display a comparable U-shaped conformation by molecular modelling, with hydrophobic cycles placed at the extremity of each branch and a peptidic bond placed at the bottom of the U. A comparable conformation was observed with the hypoglycemic sulfonylureas glibenclamide and glimepiride. A different conformation with a greater distance between the hydrophobic cycles at the extremity of each branch was found, however, with the biologically inactive enantiomers of A-4166 and repaglinide and the poorly efficient insulinotropic agent meglitinide. The identification of a common conformation of these hypoglycemic agents may help in the design of highly active compounds and provide an imprint of their postulated target receptor on the pancreatic B-cell plasma membrane.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8615868     DOI: 10.1016/s0006-2952(99)80003-3

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Stimulation of insulin and somatostatin release by two meglitinide analogs.

Authors:  V Leclercq-Meyer; L Ladrière; J Fuhlendorff; W J Malaisse
Journal:  Endocrine       Date:  1997-12       Impact factor: 3.633

Review 2.  Regulation, perturbation, and correction of metabolic events in pancreatic islets.

Authors:  W J Malaisse
Journal:  Acta Diabetol       Date:  1996-09       Impact factor: 4.280

3.  Fate of 3H- and 14C-labelled A-4166 in pancreatic islets.

Authors:  F Malaisse-Lagae; W J Malaisse
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

4.  How different sterols contribute to saponin tolerant plasma membranes in sea cucumbers.

Authors:  Emily J S Claereboudt; Igor Eeckhaut; Laurence Lins; Magali Deleu
Journal:  Sci Rep       Date:  2018-07-18       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.